IL1R1 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-IL1R1 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | IL1R1 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human |
| Isotype | n/a |
| Format | Protein G purified |
| Size | 0.05 mg, 0.1 mg |
| Concentration | n/a |
| Applications | ELISA (EIA), Immunofluorescence (IF) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Receptor for IL1A, IL1B and IL1RN. After binding to interleukin-1 associates with the coreceptor IL1RAP to form the high affinity interleukin-1 receptor complex which mediates interleukin-1-dependent activation of NF-kappa-B, MAPK and other pathways. Signaling involves the recruitment of adapter molecules such as TOLLIP, MYD88, and IRAK1 or IRAK2 via the respective TIR domains of the receptor/coreceptor subunits. Binds ligands with comparable affinity and binding of antagonist IL1RN prevents association with IL1RAP to form a signaling complex. |
| Immunogen | Immunogen: Recombinant Human Interleukin-1 receptor type 1 protein (18-320AA) Conjugation: Non-conjugated |
| Other Names | [Interleukin-1 receptor type 1; IL-1R-1; IL-1RT-1; IL-1RT1; CD121 antigen-like family member A; Interleukin-1 receptor alpha; IL-1R-alpha; Interleukin-1 receptor type I; p80; CD121a; Interleukin-1 receptor type 1; membrane form; mIL-1R1; mIL-1RI; Interleukin-1 receptor type 1; soluble form; sIL-1R1; sIL-1RI; IL1R1; IL1R; IL1RA; IL1RT1] |
| Gene, Accession # | [IL1R1], Gene ID: 3554, NCBI: NP_000868.1, UniProt: P14778 |
| Catalog # | MBS7052081 |
| Price | $160, $235 |
| Order / More Info | IL1R1 Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies